Status:
COMPLETED
Identifying Prostate Brachytherapy Seeds Using MRI
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study will look at the feasibility of using a type of Magnetic Resonance Imaging called Susceptibility Weighted Imaging (SWI) to detect your implanted radioactive seeds. Researchers hope that usi...
Eligibility Criteria
Inclusion
- At least 18 years old
- Histologic diagnosis of adenocarcinoma of the prostate
- No contraindications for Pelvic body MRI
- Patients undergoing LDR brachytherapy at PMH and scheduled for post implant analysis with CT-MR (standard at PMH)
- Ability to provide written informed consent to participate in the study
Exclusion
- Contraindication for Pelvic body MRI
- Patient not willing/consenting for this study
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01878058
Start Date
October 1 2012
End Date
August 1 2016
Last Update
November 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, The Princess Margaret
Toronto, Ontario, Canada, M5G 2M9